Home delivery of the communicator for remote monitoring of cardiac implantable devices: A multicenter experience during the covid‐19 lockdown
Autor: | Roberto Rordorf, Antonino Nicosia, Sergio Valsecchi, Davide Saporito, Monica Campari, Michele Magnocavallo, Paola Vaccaro, Giuseppe Giunta, Massimiliano Marini, Carlo Lavalle, Antonio Rapacciuolo, Marco Valerio Mariani, Agostino Piro, Alessia Bernardini, Stefano Grossi, Carmen Adduci, Francesco Pentimalli, Giuseppe Santarpia |
---|---|
Rok vydání: | 2021 |
Předmět: |
Male
Pacemaker Artificial 2019-20 coronavirus outbreak Coronavirus disease 2019 (COVID-19) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Physical Distancing Pneumonia Viral Viral transmission 030204 cardiovascular system & hematology cardiac implantable electronic device 03 medical and health sciences 0302 clinical medicine Devices medicine Humans 030212 general & internal medicine Pandemics covid‐19 remote monitoring follow‐up Protocol (science) SARS-CoV-2 business.industry Incidence COVID-19 Arrhythmias Cardiac General Medicine medicine.disease Home Care Services Patient preference Defibrillators Implantable Italy Median time Remote Sensing Technology Female Medical emergency Cardiology and Cardiovascular Medicine business covid-19 follow-up arrhythmias Cardiac female humans incidence male pacemaker artificial pandemics pneumonia viral remote sensing technology defibrillators implantable home care services physical distancing |
Zdroj: | Pacing and Clinical Electrophysiology |
ISSN: | 1540-8159 0147-8389 |
Popis: | Background During the COVID‐19 pandemic in‐person visits for patients with cardiac implantable electronic devices should be replaced by remote monitoring (RM), in order to prevent viral transmission. A direct home‐delivery service of the RM communicator has been implemented at 49 Italian arrhythmia centers. Methods According to individual patient preference or the organizational decision of the center, patients were assigned to the home‐delivery group or the standard in‐clinic delivery group. In the former case, patients received telephone training on the activation process and use of the communicator. In June 2020, the centers were asked to reply to an ad hoc questionnaire to describe and evaluate their experience in the previous 3 months. Results RM was activated in 1324 patients: 821 (62%) received the communicator at home and the communicator was activated remotely. Activation required one additional call in 49% of cases, and the median time needed to complete the activation process was 15 min [25th‐75th percentile: 10–20]. 753 (92%) patients were able to complete the correct activation of the system. At the time when the questionnaire was completed, 743 (90%) communicators were regularly transmitting data. The service was generally deemed useful (96% of respondents) in facilitating the activation of RM during the COVID‐19 pandemic and possibly beyond. Conclusions Home delivery of the communicator proved to be a successful approach to system activation, and received positive feedback from clinicians. The increased use of a RM protocol will reduce risks for both providers and patients, while maintaining high‐quality care. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |